Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Dow
McKesson
Mallinckrodt
Colorcon
Chubb
Harvard Business School
Boehringer Ingelheim

Generated: May 22, 2018

DrugPatentWatch Database Preview

BROMDAY Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Bromday patents expire, and when can generic versions of Bromday launch?

Bromday is a drug marketed by Bausch And Lomb Inc and is included in one NDA.

The generic ingredient in BROMDAY is bromfenac sodium. Five suppliers are listed for this compound. Additional details are available on the bromfenac sodium profile page.
Summary for BROMDAY
Drug patent expirations by year for BROMDAY
Pharmacology for BROMDAY
Synonyms for BROMDAY
120638-55-3
2-AMINO-3-(4-BROMOBENZOYL)BENZENEACETIC ACID SODIUM SALT
2-Amino-3-(4-bromobenzoyl)benzeneacetic Acid Sodium Salt Hydrate
2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID SODIUM
2285AH
91714-93-1
9X8YF771OU
AC-149
AC-9334
AHR-10282B
AKOS000280377
AN-594
API0000432
BC005156
BC238440
Benzeneacetic acid, 2-amino-3-(4-bromobenzoyl)-, monosodium salt
Benzeneacetic acid,2-amino-3-(4-bromobenzoyl)-,monosodium salt
BROMFENAC SODIUM
Bromfenac sodium anhydrous
bromfenac sodium salt
Bromfenac sodium, >=98% (HPLC)
Bronuck
C15H11BrNO3.Na
CHEBI:140536
CHEMBL751
CTK8E6674
DTXSID70273981
FT-0080506
FT-0084337
FT-0602701
FT-0660252
HMS3652D21
HZFGMQJYAFHESD-UHFFFAOYSA-M
I14-15725
J-004372
KS-00000654
KS-1199
MFCD03701673
MolPort-005-938-273
Q-200752
RT-011819
s4248
SC-82804
SCHEMBL56644
Sodium (2-amino-3-(4-bromobenzoyl)phenyl)acetate
sodium [2-amino-3-(4-bromobenzoyl)phenyl]acetate
sodium 2-[2-amino-3-(4-bromobenzoyl)phenyl]acetate
sodium 2-amino-3-(4-bromobenzoyl) phenylacetate
Sodium; [2-amino-3-(4-bromo-benzoyl)-phenyl]-acetate
UNII-9X8YF771OU

US Patents and Regulatory Information for BROMDAY

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb Inc BROMDAY bromfenac sodium SOLUTION/DROPS;OPHTHALMIC 021664-002 Oct 16, 2010 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Covington
Cerilliant
UBS
Fuji
McKesson
Healthtrust
Julphar
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.